DENVER, Colo. (247marketnews.com) – The final stretch of trading is bringing a fresh batch of catalysts across biotech, energy, AI and digital assets, with the following names delivering developments capable of reshaping their narratives. Aethlon Medical (NASDAQ:AEMD), NeOnc Technologies Holdings (NASDAQ:NTHI), bioAffinity Technologies (NASDAQ:BIAF), Turbo Energy (NASDAQ:TURB), CID HoldCo (NASDAQ:DAIC), Paradium.AI (NYSE:PAAI), StablecoinX (NASDAQ:USDE), FuelCell Energy (NASDAQ:FCEL), and Schrödinger (NASDAQ:SDGR).
Aethlon Medical
Aethlon (NASDAQ:AEMD) is undergoing a dramatic strategic reset after announcing an all-stock merger with privately held North Immunology and an oversubscribed financing expected to generate approximately $180 million. If completed, the combined company is expected to operate as North Immunology and trade under NASDAQ:NRTX, with the transaction targeted for the first quarter of 2027.
The deal puts North Immunology’s NOR-101, an IL-13 × IL-18 bispecific antibody for atopic dermatitis, at the center of the story. The company expects to begin a Phase 1a study in Q1 2027, with interim pharmacokinetic and safety data targeted for mid-2027 and Phase 1b and Phase 2b topline results expected in 2028. The proposed transaction would leave legacy Aethlon shareholders with approximately 4.75% of the combined company, plus contingent value rights tied to potential monetization of the Hemopurifier business.
NeOnc Technologies Holdings
NeOnc (NASDAQ:NTHI) delivered a notable capital-structure cleanup, redeeming all 6,000 outstanding Series A Convertible Preferred shares for $6 million in cash without issuing common shares. The redemption was funded with proceeds from the company’s recently announced $15 million registered direct offering.
The move removes a preferred security that carried a discounted common-stock conversion feature. CEO Amir F. Heshmatpour said the company made a “deliberate decision” to eliminate the potential dilution. With NEO100 and NEO212 advancing through clinical development, the focus now shifts toward how NeOnc deploys its capital against its CNS oncology pipeline.
bioAffinity Technologies
bioAffinity (NASDAQ:BIAF) added another piece to its intellectual-property portfolio after receiving a Hong Kong patent covering technology underlying its CyPath Lung diagnostic. The grant complements patent protection in China and broader filings across international markets, strengthening the company's stated IP position as it pursues commercial opportunities for its noninvasive lung-cancer detection technology.
CyPath Lung uses sputum, fluorescent markers and flow cytometry to help assess the likelihood of malignancy in patients with lung nodules. The company has previously reported clinical performance of 92% sensitivity, 87% specificity and 99% negative predictive value in a high-risk patient population with small indeterminate lung nodules. The test remains a Laboratory Developed Test and is not intended to be used as a standalone diagnostic.
Turbo Energy
Turbo Energy (NASDAQ:TURB) closed out the session with another tangible commercial-storage catalyst, announcing 15 firm-order commercial and industrial projects across Spain and Chile representing approximately 15.6 MWh of storage capacity and 5.95 MW of power. The aggregate order value attributable to Turbo Energy is estimated at approximately €3 million, or about $3.48 million.
The project portfolio spans solar time-shifting, self-consumption optimization, peak-demand management, EV charging, off-grid power and grid-interruption mitigation. Two systems are already operating, three are under installation and nine are in manufacturing, while one remains under development. The company expects the projects not yet operating to progress through delivery and commissioning from Q4 2026 into H1 2027, subject to project-specific conditions. The portfolio is separate from Turbo Energy’s previously announced 366 MWh, $53 million Pamesa Net Zero deployment.
CID HoldCo
CID HoldCo (NASDAQ:DAIC) emerged as another notable mover after filings disclosed a planned $65 million acquisition of Envoy Technologies, adding a significant corporate-development catalyst to the story. The company also disclosed a debt settlement involving approximately $1.09 million that was converted into shares.
The transaction is targeted for completion by October 6, with definitive agreements expected by September 25, while the company has also submitted a plan related to Nasdaq listing compliance. With an acquisition deadline approaching, the next filings and transaction milestones could become important near-term developments for DAIC.
Paradium.AI (NYSE:PAAI) was at the center of one of the day's largest headline developments after Roundtable announced a 10-year, $1 billion agreement involving the migration of The Arena Group’s media portfolio to Roundtable’s AI/DeFi MediaOS. The agreement represents a major commercial-development headline for the emerging AI-focused company.
The size and duration of the announced agreement immediately put Paradium.AI into focus, although investors will ultimately be watching execution, implementation and the financial impact of the arrangement. For PAAI, the announcement adds a substantial commercial narrative to an increasingly crowded AI market.
StablecoinX
StablecoinX (NASDAQ:USDE) disclosed a waiver agreement with Ethena that is expected to permanently remove certain lock-up, vesting and unlocking restrictions on ENA tokens held by or deliverable to the company, effective October 5, 2026. The filing provides another important development for the company's digital-asset strategy.
While the agreement was entered into September 14, the disclosure arrived today, making it part of the session’s fresh news flow. The next issue for investors is how the changed restrictions affect StablecoinX’s flexibility around its ENA holdings and broader digital-asset strategy.
FuelCell Energy
FuelCell Energy (NASDAQ:FCEL) generated fresh attention today, although its news flow was driven primarily by investor-related securities litigation announcements rather than a new operating contract, financing or technology milestone. Multiple law firms publicized potential securities claims involving the company.
That distinction matters when assessing the catalyst. The legal headlines can influence trading activity and investor attention, but they represent a different category of development from the commercial and clinical catalysts appearing elsewhere in today’s small-cap universe.
Schrödinger
Schrödinger (NASDAQ:SDGR) also reported fresh corporate news, announcing inducement equity grants covering 2,243 shares to three newly hired employees under its 2021 Inducement Equity Incentive Plan.
The announcement is relatively limited compared with the larger strategic and commercial developments elsewhere in this roundup. Still, it represents current company-specific news and provides another data point for investors tracking SDGR into the close.
About 24/7 Market News
In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247mnn.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
This is a paid editorial communication intended for informational purposes only. 24/7 is compensated by NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. For further disclosure information, please click here. This should not be construed as financial or investment advice. Trading involves substantial risk; consult your financial advisor.
Important Editorial Note: 247 highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication. Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.
CONTACT:
24/7 Market News
Editor@247mnn.com
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.